AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1857725
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (3 g as Ca/day)
Trial: 1857725
Drug: Normal Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal Calcium intake (536 +/- 2 mg/day)
Trial: 28299831
Drug: Ageratina pichinchensis
RxNorm normalized name: Ageratina herbacea whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ageratina pichinchensis extract (7% standardized, intravaginally administered for 6 days)
Trial: 28299831
Drug: Clotrimazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole (100 mg, positive control)
Trial: 23529834
Drug: Compound Phyllanthus
RxNorm normalized name: Phyllanthus niruri top extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Phyllanthus Urinaria L. (CPUL) for 3 years
Trial: 21739267
Drug: Coadministration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coadministration of fluvoxamine (100 mg/day) with aripiprazole (3 mg)
Trial: 2512632
Drug: Ranitidine (dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (dosing at early evening)
Trial: 2512632
Drug: Placebo (dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (dosing at nighttime)
Trial: 23375965
Drug: 0.4 g
RxNorm normalized name: psyllium 0.4 GM Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g intravenous immunoglobulin per kg every 2 weeks
Trial: 23375965
Drug: 0.1 g
RxNorm normalized name: BIOTIN 0.1 g in 100 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 g intravenous immunoglobulin per kg every 2 weeks
Trial: 21854192
Drug: Ipragliflozin 200
RxNorm normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 200 mg
Trial: 23163880
Drug: Ipragliflozin 300
RxNorm normalized name: canagliflozin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 300 mg
Trial: 19358784
Drug: Venlafaxine ER
RxNorm normalized name: Venlafaxine ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine ER (75-225 mg/d)
Trial: 16476042
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - 2 mg of estradiol plus 1 mg norethisterone acetate (n = 20)
Trial: 16476042
Drug: Alendronate -
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate - 10 mg (n = 18)
Trial: 16476042
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HRT and Alendronate (n = 22)
Trial: 8515109
Drug: Albendazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (200 mg; n = 11)
Trial: 31702699
Drug: Carbohydrate group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate group (200 mL of apple or grape juice every 3 hours)
Trial: 29808711
Drug: Intensive pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intensive pharmaceutical care
Trial: 876324
Drug: Antacid regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid regimen
Trial: 30538299
Drug: Metformin dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin dosage reduction
Trial: 28074788
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg intravenous unfractionated heparin
Trial: 28074788
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg intravenous unfractionated heparin
Trial: 24988118
Drug: Daily 7000
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daily 7000 IU vitamin D3 supplementation
Trial: 21777268
Drug: Extraction of
RxNorm normalized name: tree of heaven pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraction of 25 hopeless teeth and replacement with conventional or implant-supported fixed partial dentures
Trial: 18438234
Drug: CPS (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPS (5 g Cr + 4 g phosphate)
Trial: 18438234
Drug: Placebo (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (20 g dextrose)
Trial: 10868712
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (750 microg twice daily via Diskus)
Trial: 10868712
Drug: Budesonide (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (800 microg twice daily via Turbuhaler)
Trial: 2860157
Drug: 10% PVP‐I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% PVP‐I ointment mixed with a proteolytic agent
Trial: 2860157
Drug: 5% PVP‐I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% PVP‐I cream with proteolytic agent
Trial: 28772248
Drug: Product Evaluation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Product Evaluation Scale (PES) and Drug Effects Questionnaire (DEQ) ratings
Trial: 27075314
Drug: NRL001 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRL001 10 mg
Trial: 17051504
Drug: Ritonavir-boosted protease
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir-boosted protease inhibitor (CPI/r)
Trial: 20433721
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation with polyethylene glycol (Group A)
Trial: 20433721
Drug: No mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No mechanical bowel preparation (Group B)
Trial: 10170449
Drug: Morphine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine + midazolam
Trial: 7524379
Drug: Reogluman administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reogluman administration
Trial: 20130603
Drug: 6-mercaptopurine/methotrexate (MTX)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-mercaptopurine/methotrexate (MTX) maintenance therapy
Trial: 16706649
Drug: Antioxidant/NO‐modulating fermented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant/NO‐modulating fermented papaya preparation (FPP) 9 g/day for 4 weeks
Trial: 8404096
Drug: Pyridostigmine (PY)
DrugBank: Pyridostigmine (DB00545)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pyridostigmine (PY) 30 mg orally three times a day
Trial: 3780824
Drug: Metoclopramide 1
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 1 and 2 mg/kg i.v. X 5
Trial: 3595666
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose metoclopramide
Trial: 22631865
Drug: Immediate postpartum
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate postpartum etonogestrel implant (IPI) insertion
Trial: 17924051
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for hip fractures
Trial: 8551821
Drug: Intravenous glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous glyceryl trinitrate
Trial: 28780512
Drug: 30 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg/kg dapirolizumab pegol followed by 15 mg/kg every 2 weeks for 10 weeks
Trial: 24702239
Drug: 4% articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% articaine buccal infiltration (1.8 mL with 1:100,000 epinephrine)
Trial: 25689936
Drug: Tolvaptan 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 7.5 mg
Trial: 19007589
Drug: Tolvaptan 15
RxNorm normalized name: tolvaptan 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 15 mg
Trial: 19151304
Drug: 6% hydroxyethyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hydroxyethyl starch solution
Trial: 3531141
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day drug
Trial: 3531141
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day drug (tolerance study)
Trial: 25581217
Drug: Whole-body vibration
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-body vibration (WBV) 0.3g at 37 Hz for 10 minutes daily
Trial: 1679047
Drug: Xamoterol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol (200 mg twice daily)
Trial: 2572251
Drug: Digoxin (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin (0.125 mg twice daily)
Trial: 22168507
Drug: Computerised cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerised cognitive behavioural therapy (CCBT)
Trial: 11494079
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg initially, increased to 100 mg or decreased to 25 mg based on efficacy and toleration)
Trial: 9541846
Drug: Iopentol with
RxNorm normalized name: iopentol
DrugBank: Iopentol (DB13861)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iopentol with 150 mg iodine/ml (viscosity 1.7 mPas, osmolality 340 mOsmol/kg H2O)
Trial: 9541846
Drug: High-viscosity radiocontrast
RxNorm normalized name: Mineral Oil (high Viscosity)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-viscosity radiocontrast agents
Trial: 10371541
Drug: Gradual dose
RxNorm normalized name: MEDICINE DOSE CUP GRADUATED 30ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gradual dose escalation of interferon beta-1b
Trial: 10371541
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ibuprofen treatment and gradual dose escalation of interferon beta-1b
Trial: 1768559
Drug: Prochlorperazine (PCZ)
RxNorm normalized name: Prochlorperazine
DrugBank: Prochlorperazine (DB00433)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (PCZ) 25 mg twice daily for 14 days
Trial: 6344550
Drug: Urabe Am
RxNorm normalized name: Urate oxidase
DrugBank: Rasburicase (DB00049)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Urabe Am 9 strain of live attenuated mumps vaccine
Trial: 31427751
Drug: Immunomodulatory drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunomodulatory drugs (general)
Trial: 21919823
Drug: Subcutaneous alemtuzumab
RxNorm normalized name: Alemtuzumab
DrugBank: Alemtuzumab (DB00087)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous alemtuzumab 10 mg three times a week for 18 weeks
Trial: 21919823
Drug: Subcutaneous alemtuzumab
RxNorm normalized name: Alemtuzumab
DrugBank: Alemtuzumab (DB00087)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous alemtuzumab 30 mg once weekly after lymphocyte count reduction by 1 Log in 18 patients
Trial: 7470781
Drug: Amipaque (metrizamide)
RxNorm normalized name: metrizamide
DrugBank: Metrizamide (DB01578)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amipaque (metrizamide) 370 mg iodine/ml
Trial: 7470781
Drug: Amipaque (metrizamide)
RxNorm normalized name: metrizamide
DrugBank: Metrizamide (DB01578)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amipaque (metrizamide) 300 mg iodine/ml
Trial: 28779269
Drug: Non-heme iron
RxNorm normalized name: Heme iron polypeptide
DrugBank: Heme iron polypeptide (DB11067)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-heme iron (FeSO4, 195 mg/day)
Trial: 28779269
Drug: Heme iron
RxNorm normalized name: HEME IRON
DrugBank: Ferroheme (DB18267)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heme iron (heme-iron-polypeptide, HIP, 31.5 to 94.5 mg/day)
Trial: 27129315
Drug: Upper tertile
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Upper tertile U-Cd (≥0.42 μg/g Cr)
Trial: 29061084
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (regular physical therapy)
Trial: 15598939
Drug: NX (vinorelbine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NX (vinorelbine 25 mg/m(2) days 1 and 8, capecitabine 2000 mg/m(2) days 1‐14, every 21 days)
Trial: 10736083
Drug: Rectal codeine
RxNorm normalized name: Codeine
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal codeine phosphate (1 mg.kg‐1)
Trial: 10736083
Drug: Intramuscular codeine
RxNorm normalized name: Codeine
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular codeine phosphate (1 mg.kg‐1)
Trial: 1439070
Drug: Isosorbide 5‐Mononitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide 5‐Mononitrate 50 mg sustained release administered once daily
Trial: 31522153
Drug: Combined orthodontic
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined orthodontic regenerative therapy alone (Group II: control group)
Trial: 27196567
Drug: Oral ixazomib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ixazomib 3 mg
Trial: 23231377
Drug: Traditional balance
RxNorm normalized name: Rebalance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional balance therapy
Trial: 16137243
Drug: Concurrent motor
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent motor task
Trial: 2276321
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg calcium supplementation
Trial: 22350761
Drug: Pharmacist-assisted medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-assisted medication reconciliation
Trial: 19850525
Drug: Alteplase (0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alteplase (0.9 mg/kg bodyweight)
Trial: 2523870
Drug: ramipril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ramipril (5 mg)
Trial: 2523870
Drug: captopril (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: captopril (12.5 mg)
Trial: 25997548
Drug: NRL972 (Fluorescein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NRL972 (Fluorescein Lisicol) 2 mg IV injection
Trial: 15195596
Drug: IgY stomat-spray
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IgY stomat-spray (30 doses, 6 times daily, titer = 512)
Trial: 11773155
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment burden estimation using LASA indicators
Trial: 9404372
Drug: Frusemide (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (4 ml x 10 mg/ml)
Trial: 11519503
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg immediately, followed by 75 mg once daily)
Trial: 26907087
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (CM) 2g daily for 8 weeks
Trial: 26907087
Drug: Creatine monohydrate
RxNorm normalized name: Creatine Monohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine monohydrate (CM) 4g daily for 8 weeks
Trial: 15728066
Drug: Preemptive NSAID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive NSAID administration
Trial: 11804984
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg per os per day
Trial: 11804984
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of estrogens and ramipril
Trial: 1646194
Drug: Thoracic megavoltage
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic megavoltage radiotherapy preceded and followed by 3 monthly cycles of VCPC (vindesine 1.5 mg/m2 d 1‐2, cyclophosphamide 200 mg/m2 d 2‐4, cisplatinum 100 mg/m2 d 2, lomustine 75 mg/m2 d 3)
Trial: 30586700
Drug: Oral Anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Anticoagulation (OAC) alone
Trial: 30586700
Drug: Combined OAC
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined OAC and single Antiplatelet Therapy (APT)
Trial: 27475283
Drug: C. vulgaris
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C. vulgaris (four 300 mg tablets)
Trial: 27475283
Drug: Placebo (four
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (four 300 mg tablets)
Trial: 19651272
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation therapy (noncycling control group)
Trial: 16314627
Drug: Low-dose leucovorin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose leucovorin plus fluorouracil (Mayo Clinic; LDLV) regimen for 30 to 32 weeks
Trial: 16314627
Drug: High-dose leucovorin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose leucovorin plus fluorouracil (Roswell Park; HDLV) regimen for 30 to 32 weeks
Trial: 9630000
Drug: Quetiapine 225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 225 mg bd
Trial: 9630000
Drug: Quetiapine 150
RxNorm normalized name: quetiapine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 150 mg tid
Trial: 9630000
Drug: Quetiapine 50
RxNorm normalized name: quetiapine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine 50 mg bd
Trial: 3345339
Drug: Nifedipine (orally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (orally administered)
Trial: 26614142
Drug: Intrathecal 2.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal 2.5mg hyperbaric levobupivacaine plus 25 μg fentanyl
Trial: 21621169
Drug: Institutional-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Institutional-based therapy (IT)
Trial: 16404099
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (CT)
Trial: 8770972
Drug: Intravenous calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous calcitriol (2 micrograms) and 3.5 mEq/liter calcium dialysate for six weeks
Trial: 6361099
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (randomizable group)
Trial: 6361099
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy (randomizable group)
Trial: 30698487
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg pirfenidone
Trial: 19140204
Drug: 0.01 mg/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg/d rhIL-18
Trial: 19140204
Drug: 0.1 mg/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg/d rhIL-18
Trial: 19140204
Drug: 1.0 mg/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg/d rhIL-18
Trial: 19140204
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (0.01, 0.1, 1.0 mg/kg/d rhIL-18)
Trial: 12427437
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous glucagon (Control)
Trial: 10075343
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g oligofructose/d
Trial: 10075343
Drug: sucrose (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucrose (control treatment)
Trial: 7559195
Drug: Cefotiam hexetil
RxNorm normalized name: Cefotiam hexetil hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotiam hexetil (CTM) 200 mg bd for 5 days
Trial: 7559195
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (PEV) 1 megaunit (600 mg) tds for 10 days
Trial: 29709070
Drug: Inactive device
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactive device (sham treatment)
Trial: 25102685
Drug: Western Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western Medicine (n = 60)
Trial: 20708062
Drug: Mandibular 2‐implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular 2‐implant overdentures (IODs)
Trial: 17420340
Drug: Sequential Biventricular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential Biventricular (BiV) pacing
Trial: 17420340
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups (Simultaneous BiV, Sequential BiV, LV pacing)
Trial: 15746297
Drug: Intranasal phenoxybenzamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal phenoxybenzamine
Trial: 11978254
Drug: Delayed prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed prescription
Trial: 11978254
Drug: Immediate prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate prescription
Trial: 8033492
Drug: Intravenous torsemide
RxNorm normalized name: Torsemide
DrugBank: Torasemide (DB00214)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous torsemide
Trial: 8033492
Drug: Oral torsemide
RxNorm normalized name: Torsemide
DrugBank: Torasemide (DB00214)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral torsemide